Literature DB >> 32519534

LncRNA OIP5-AS1 induces epithelial-to-mesenchymal transition and renal fibrosis in diabetic nephropathy via binding to miR-30c-5p.

J X Fu1, G Q Sun1, H L Wang1, H X Jiang1.   

Abstract

NIn recent years, the incidence of diabetic nephropathy (DN) is rising, and is one of the most important complications of diabetic patients. In this study, the role and regulatory mechanism of lncRNA OIP5-AS1 in the regulation of DN were investigated. Here, the expressions of lncRNA OIP5-AS1 and miR-30c-5p were detected by RT-qPCR. Western blot analysis was used to detect the protein expression of E-cadherin, N-cadherin, TGF-β1, α-SMA. The relationship between OIP5-AS1 and miR-30c-5p was confirmed by dual luciferase reporter assay. The results showed that the expression of lncRNA OIP5-AS1 was increased in db/db DN mice kidney tissue and high glucose-stimulated HK2 cells. lncRNA OIP5-AS1 promoted epithelial-to-mesenchymal transition (EMT) and renal fibrosis in high glucose-stimulated HK2 cells. In addition, lncRNA OIP5-AS1 directly targets miR-30c-5p, and lncRNA OIP5-AS1 negatively regulated miR-30c-5p expression in high glucose-stimulated HK2 cells. More importantly, overexpression of miR-30c-5p attenuated the promoting effect of OIP5-AS1 on EMT and renal fibrosis in high glucose-stimulated HK2 cells. In conclusion, lncRNA OIP5-AS1 induces EMT and renal fibrosis in DN via binding to miR-30c-5p. Copyright 2020 Biolife Sas. www.biolifesas.org.

Entities:  

Keywords:  LncRNA OIP5-AS1; diabetic nephropathy; epithelial-to-mesenchymal transition; miR-30c-5p; renal fibrosis

Mesh:

Substances:

Year:  2020        PMID: 32519534     DOI: 10.23812/20-199-A-68

Source DB:  PubMed          Journal:  J Biol Regul Homeost Agents        ISSN: 0393-974X            Impact factor:   1.711


  6 in total

1.  Expression of LncRNA KCNQ1Ot1 in diabetic nephropathy and its correlation with MEK/ERK signaling pathway.

Authors:  Xuangeng Huang; Junhua Tan; Yingrong Li; Hongye Su; Meiying Huang; Feifan Huang; Peng Huang
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060

2.  Circulating expression and clinical significance of LncRNA ANRIL in diabetic kidney disease.

Authors:  Yanting Zhu; Lixia Dai; Xiangyou Yu; Xintian Chen; Zhenjiang Li; Yan Sun; Yan Liang; Bing Wu; Qiong Wang; Xiaoming Wang
Journal:  Mol Biol Rep       Date:  2022-09-21       Impact factor: 2.742

3.  LncRNA PVT1 Regulates High Glucose-Induced Viability, Oxidative Stress, Fibrosis, and Inflammation in Diabetic Nephropathy via miR-325-3p/Snail1 Axis.

Authors:  Baoyu Qin; Xiaoli Cao
Journal:  Diabetes Metab Syndr Obes       Date:  2021-04-19       Impact factor: 3.168

4.  Kidney microRNA Expression Pattern in Type 2 Diabetic Nephropathy in BTBR Ob/Ob Mice.

Authors:  Lucas Opazo-Ríos; Antonio Tejera-Muñoz; Manuel Soto Catalan; Vanessa Marchant; Carolina Lavoz; Sebastián Mas Fontao; Juan Antonio Moreno; Marta Fierro Fernandez; Ricardo Ramos; Beatriz Suarez-Alvarez; Carlos López-Larrea; Marta Ruiz-Ortega; Jesús Egido; Raúl R Rodrigues-Díez
Journal:  Front Pharmacol       Date:  2022-03-16       Impact factor: 5.810

Review 5.  Long Non-Coding RNAs in the Pathogenesis of Diabetic Kidney Disease.

Authors:  Mengsi Hu; Qiqi Ma; Bing Liu; Qianhui Wang; Tingwei Zhang; Tongtong Huang; Zhimei Lv
Journal:  Front Cell Dev Biol       Date:  2022-04-20

6.  LncRNA OIP5-AS1 reduces renal epithelial cell apoptosis in cisplatin-induced AKI by regulating the miR-144-5p/PKM2 axis.

Authors:  Siyuan Chang; Mingyang Chang; Gang Liu; Daqian Xu; Haili Wang; Rongqing Sun; Min Feng
Journal:  Biomed J       Date:  2021-07-24       Impact factor: 7.892

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.